Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H20N2O |
| Molecular Weight | 232.3214 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N1CCCC1)C(=O)NC2=C(C)C=CC=C2
InChI
InChIKey=WJOQWLQQCYYQBE-UHFFFAOYSA-N
InChI=1S/C14H20N2O/c1-11-7-3-4-8-13(11)15-14(17)12(2)16-9-5-6-10-16/h3-4,7-8,12H,5-6,9-10H2,1-2H3,(H,15,17)
| Molecular Formula | C14H20N2O |
| Molecular Weight | 232.3214 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Aptocaine (Pirothesin, Pharmaceutical Manufacturing Company) is a new local anaesthetic agent, the first of note to be synthesized in Britain. It is related toprilocaine; like prilocaine, it has a low sub-cutaneous toxicity, but preliminary studies suggest that, unlike prilocaine, it does not induce methaemoglobinaemia. It has been found to produce satisfactory analgesia, of longer duration than lignocaine, by several routes, at a concentration of 3% in animals.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:29:05 GMT 2023
by
admin
on
Fri Dec 15 15:29:05 GMT 2023
|
| Record UNII |
08K838NNTE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
08K838NNTE
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
100000087165
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
71695
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
2644
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
19281-29-9
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
242-932-2
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
DTXSID40864880
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
C72172
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
SUB05549MIG
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
C012187
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104078
Created by
admin on Fri Dec 15 15:29:05 GMT 2023 , Edited by admin on Fri Dec 15 15:29:05 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
